Inaugural Winners to Be Celebrated at a Ceremony in New York on September 16
Winners in First Annual Stevie® Awards for Technology Excellence Announced
The awards celebrate the remarkable accomplishments of individuals, teams, and organizations shaping the future of technology across all industry sectors.
FAIRFAX, Va., Aug. 07, 2024 (GLOBE NEWSWIRE) — Winners in the 2024 (first annual) Stevie® Awards for Technology Excellence, “the Olympics for technology,” were announced today. The awards celebrate the remarkable accomplishments of individuals, teams, and organizations shaping the future of technology across all industry sectors. Individuals and organizations worldwide are eligible to enter – public and private, for-profit and non-profit, large and small.
Among the organizations with multiple Stevie Award wins are Amazon/Amazon Web Services (9), IBM (5), the City of Sydney, Australia (4), Gabriel Marketing Group, on behalf of several of their clients (4), Impel (4), LandGate (4), Lenovo/Lenovo India Pvt Ltd/ Lenovo PCCW Solutions (LPS) (4), BostonGene (3), Cisco Systems Inc. (3), CleverTap (3), Google (3), Gov2Biz Inc (3), MicroHealth, LLC (3), and Three Rings (3).
Winners will be celebrated during a gala awards banquet on Monday, September 16 at the Marriott Marquis Hotel in New York City. Tickets are now on sale. The presentations will be broadcast live.
More than 600 nominations from organizations in 21 nations and territories were evaluated in this year’s competition. Winners were determined by the average scores of more than 100 professionals worldwide, acting as judges. The Stevie Awards for Great Employers recognize achievement in many facets of the workplace. Categories are grouped in 20 technology-industry sections:
Advertising, Marketing & Public Relations Technology
Aerospace Technology
Agricultural Technology
Architectural Technology
Artificial Intelligence
Assistive Technology
Biotechnology
Business Technology
Communication Technology
Educational Technology
Energy Technology
Entertainment Technology
Financial Technology
Government Technology
Green and Clean Technology
Healthcare Technology
Information Technology
Manufacturing Technology
Marine Technology
Transportation Technology
The awards are presented by the Stevie Awards, organizer of nine of the world’s leading business awards shows including the prestigious International Business Awards® and American Business Awards®.
About the Stevie Awards
Stevie Awards are conferred in nine programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, the Stevie Awards for Technology Excellence, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.
هانوي فيتنام – 7 أغسطس 2024مجموعة Vingroup، وهي أكبر تكتل تجاري خاص في فيتنام، رسخت وجودها بقوة في قطاعات متنوعة مثل العقارات والتكنولوجيا والضيافة والرعاية الصحية والتعليم. مع ذلك، لا يُعزى نجاح Vingroup إلى التوسع الطموح فحسب، بل إنه
مرتبط كذلك بشدة بالتزامها الثابت بتحسين أوضاع العالم وفلسفة تركز على العملاء، وهي قيمة أساسية في نهج الشركة.
أول معرض لـVinFast في الشرق الأوسط في عُمان
فلسفة Vingroup
إن فلسفة Vingroup التي تركز على العملاء ليست مجرد أسلوب تسويقي؛ بل إنها عنصر ثقافي راسخ يوجه كل قراراتها بدايةً من قرارات تصنيع المنتجات وخدمة العملاء حتى قرارات التوسع في الأسواق.
إن التفاني في خدمة العملاء ليس تطورًا حديثًا في نهج Vingroup، بل إنها تتحلى به منذ بداياتها المتواضعة في أوكرانيا عام 1993عندما كان اسمها Technocom، وأولى محاولاتها في دخول السوق بمنتجات الشعرية سريعة التحضير واجهت تحديًا فريدًا؛ فقد كان المستهلكون الأوكرانيون متشككين في المفهوم الجديد لمنتج غذائي يمكن أن يكون جاهزًا للأكل بعد طهوه في ماء مغلي لبضع دقائق.
بدلاً من اللجوء إلى أساليب التسويق التقليدية، اتبع المؤسس فام نات فونج نهجًا عمليًا، حيث تعامل مباشرةً مع العملاء المحتملين لشرح طريقة تحضير الشعرية وتوضيح بساطته، وثبت أن التفاعل المباشر وتثقيف العملاء بالغ الأهمية، ما أدى إلى إقبال كبير على استخدام المنتج.
علاوة على ذلك، عززت هذه التجربة المبكرة إدراك مديري Vingroup لارتباط النجاح بالتواصل الحقيقي مع العملاء، أي عدم اقتصار التواصل مع العملاء على شؤون المبيعات والحرص على تلبية احتياجاتهم وطلباتهم.
التركيز على العملاء عمليًا
قبل إنشاء مشاريع مثل سلسلة منتجعات Vinpearl ، درس فام نات فونج مجال الضيافة بعمق من خلال إيفاد “بعثات ميدانية” إلى تايلاند وسنغافورة، وطُبقت الخبرات المباشرة للتفاعلات مع العملاء على عروض Vinpearl ، ما ضمن تلبية الرغبات الخاصة للعائلات والسائحين الفيتناميين.
يتضح اهتمام Vingroup بتغير احتياجات العملاء في تحركها الاستراتيجي نحو مجال المركبات الكهربائية مع VinFast. استجابةً للطلب العالمي على النقل المستدام والتفضيلات الخاصة بالمستهلكين الفيتناميين، صنعت الشركة مركبات كهربائية تجمع بين التكنولوجيا المتطورة والسمات المصممة خصيصًا للسوق المحلية.
ظلت Vingroup ملتزمة للغاية بإرضاء العملاء حتى بعدما هيمنت على السوق، ويتضح هذا الالتزام في قرار VinFast بتعزيز الدعم لمالكي المركبات التي تعمل بالبنزين الحاليين حتى بعدما حولت مسار اهتمامها إلى تصنيع المركبات الكهربائية.
أكد فام نات فونج في حوار أجراه عام 2022 قائلًا: “بالنسبة لسيارات VinFast التي تعمل بالبنزين، لا نحافظ على التزاماتنا الحالية فحسب، بل ونعززها أيضًا بسياسات وخدمات أكثر فائدة، مثل تمديد فترة الضمان إلى 10 سنوات، وهو ما يزيد مرتين إلى ثلاث مرات عن السائد في المجال، وتقديم خيار خدمة الهاتف الجوال المريحة”.
VinFast شركة ناشئة تابعة لـVingroup ومتخصصة في تصنيع السيارات، وقد جعلت دعم ما بعد البيع من قيمها الأساسية، ما دفعها إلى التوسع في أمريكا الشمالية وأوروبا وآسيا وحاليًا في منطقة الشرق الأوسط، وتمهد لترسيخ أعمالها في هذه المنطقة من خلال تأسيس مقر إقليمي لها في دبي وإقامة شراكات استراتيجية.
على سبيل المثال، أول معرض لشركة VinFast في الشرق الأوسط في عُمان، والذي يقدم تجارب تفاعلية مع مركباتها الكهربائية الذكية، يُظهر التزام الشركة بتوفير حلول تنقل مستدامة وذكية. تقدم هذه المبادرات لمحة عن فلسفة VinFast التي تركز على العملاء، ما يمكنها من تقديم منتجات متنوعة وتطبيق سياسات مبتكرة وتوفير خدمات ما بعد البيع شاملة ومصممة خصيصًا للمستهلكين في الشرق الأوسط.
إن الوتيرة السريعة لـ VinFast والنجاح الأوسع نطاقًا لـ Vingroup يؤكدان أن فلسفة التركيز على العملاء تؤدي إلى إجراء تحولات جذرية. من خلال الفهم العميق لاحتياجات العملاء وإعطائها الأولوية، قامت Vingroup ببناء إمبراطورية أعمال متنوعة ومزدهرة، فتهيأت بذلك لاستمرار تطورها وتأثيرها.
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results FDA regulatory submission complete, U.S. approval on track for end of 2024 U.S. commercial launch fully funded with over €85 million in new capital raised
Mont-Saint-Guibert, Belgium – August 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the second quarter and first half of 2024.
Recent Financial and Operating Highlights
Submitted final module in the modular PMA submission, initiating FDA interactive review.
Strengthening U.S. commercial organization, highlighted by the appointments of Scott Holstine as Chief Commercial Officer and key sales, marketing and market access leaders.
Raised over €85 million in growth capital through a €48.5 million equity offering and a €37.5 million loan facility agreement with the European Investment Bank (EIB).
Reported second quarter 2024 sales of €0.8 million and first half 2024 sales growth of 29% over the same period last year.
Total cash position of €77.8 million at the end of the quarter, excluding the €37.5 million EIB loan facility.
“With the FDA interactive review well advancing, our focus is fully shifted to U.S. commercial readiness. Key commercial leadership is in place, and we are kicking off the recruitment of top sales and marketing talents. We will present the full DREAM U.S. pivotal study data at the ISSS meeting in September, which will further differentiate Genio’s unique, patient centric hypoglossal nerve stimulation solution,” commented Olivier Taelman, Nyxoah Chief Executive officer. “Our recent €85 million in capital raise provides us with a cash runway into mid-2026, fully funding the U.S. launch.”
Second Quarter and First Half 2024 Results
CONSOLIDATED STATEMENTS OF LOSS AND OTHER COMPREHENSIVE LOSS (unaudited) (in thousands)
For the three months ended June 30,
For the six months ended June 30,
2024
2023
2024
2023
Revenue
771
1,107
1,992
1,548
Cost of goods sold
(281)
(419)
(735)
(594)
Gross profit
€490
€688
€1,257
€954
Research and Development Expense
(7,472)
(6,605)
(14,671)
(12,762)
Selling, General and Administrative Expense
(6,383)
(6,185)
(12,355)
(11,736)
Other income/(expense)
58
219
249
265
Operating loss for the period
€(13,307)
€(11,883)
€(25,520)
€(23,279)
Financial income
2,069
789
3,477
1,414
Financial expense
(1,445)
( 775)
(2,436)
(1,732)
Loss for the period before taxes
€(12,683)
€(11,869)
€(24,479)
€(23,597)
Income taxes
(441)
(928)
(551)
(1,110)
Loss for the period
€(13,124)
€(12,797)
€(25,030)
€(24,707)
Loss attributable to equity holders
€ (13,124)
€(12,797)
€(25,030)
€(24,707)
Other comprehensive income/(loss)
Items that may not be subsequently reclassified to profit or loss (net of tax)
Currency translation differences
(82)
(50)
(22)
(78)
Total comprehensive loss for the year, net of tax
€(13,206)
€(12,847)
€(25,052)
€(24,785)
Loss attributable to equity holders
€(13,206)
€(12,847)
€(25,052)
€(24,785)
Basic loss per share (in EUR)
€(0.428)
€(0.447)
€(0.843)
€(0.907)
Diluted loss per share (in EUR)
€(0.428)
€(0.447)
€(0.843)
€(0.907)
CONSOLIDATED STATEMENT OF FINANCIAL POSITION (unaudited) (in thousands)
As at
June 30,
2024
December 31, 2023
ASSETS
Non-current assets
Property, plant and equipment
4,386
4,188
Intangible assets
49,310
46,608
Right of use assets
3,391
3,788
Deferred tax asset
51
56
Other long-term receivables
1,419
1,166
€ 58,557
€ 55,806
Current assets
Inventory
5,098
3,315
Trade receivables
2,609
2,758
Other receivables
2,885
3,212
Other current assets
1,298
1,318
Financial assets
50,061
36,138
Cash and cash equivalents
27,724
21,610
€ 89,675
€ 68,351
Total assets
€ 148,232
€ 124,157
EQUITY AND LIABILITIES
Capital and reserves
Capital
5,905
4,926
Share premium
290,822
246,127
Share based payment reserve
8,841
7,661
Other comprehensive income
115
137
Retained loss
(185,540)
(160,829)
Total equity attributable to shareholders
€ 120,143
€ 98,022
LIABILITIES
Non-current liabilities
Financial debt
8,600
8,373
Lease liability
2,721
3,116
Pension liability
35
9
Provisions
339
185
Deferred tax liability
10
9
€11,705
€ 11,692
Current liabilities
Financial debt
595
364
Lease liability
827
851
Trade payables
9,078
8,108
Current tax liability
2,335
1,988
Other payables
3,549
3,132
€ 16,384
€ 14,443
Total liabilities
€ 28,089
€ 26,135
Total equity and liabilities
€ 148,232
€ 124,157
Revenue
Revenue was €0.8 million for the second quarter ending June 30, 2024, compared to €1.1 million for the second quarter ending June 30, 2023.
Cost of Goods Sold
Cost of goods sold was €281,000 for the three months ending June 30, 2024, representing a gross profit of €490,000, or gross margin of 63.6%. This compares to total cost of goods sold of €419,000 in the second quarter of 2023, for a gross profit of €0.7 million, or gross margin of 62.2%.
Research and Development
For the second quarter ending June 30, 2024, research and development expenses were €7.5 million, versus €6.6 million for the second quarter ending June 30, 2023.
Operating Loss
Total operating loss for the second quarter ending June 30, 2024 was €13.3 million versus €11.9 million in the second quarter ending June 30, 2023. This was driven by the acceleration in the Company’s R&D spending, as well as ongoing commercial and clinical activities.
Cash Position
As of June 30, 2024, cash and financial assets totaled €77.8 million, compared to €57.7 million on December 31, 2023. Total cash burn was approximately €4.0 million per month during the second quarter 2024.
Second Quarter and First Half 2024
Nyxoah’s financial report for the second quarter and first half 2024, including details of the consolidated results, are available on the investor page of Nyxoah’s website (https://investors.nyxoah.com/financials).
Conference call and webcast presentation
Company management will host a conference call to discuss financial results on Tuesday, August 6, 2024, beginning at 10:30pm CET / 4:30pm ET.
A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link:Nyxoah’s Q2 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Nyxoah’s Q2 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
The archived webcast will be available for replay shortly after the close of the call.
About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.
Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.
For more information, please see the Company’s annual report for the financial year 2023and visit http://www.nyxoah.com/.
Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.
Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the entry into of the loan facility agreement and the synthetic warrant agreement with the EIB; the use of proceeds from the loan facility agreement; the Genio® system and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; reporting data from Nyxoah’s DREAM U.S. pivotal trial; filing for FDA approval; and entrance to the U.S. market. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.
Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer IR@nyxoah.com
For Media
Belgium/France
Backstage Communication – Gunther De Backer gunther@backstagecom.be
Abha, The Aseer Municipality, represented by Al-Naqi Municipality, announced the launch of seven investment opportunities through the Municipal Investment Portal “Furas” for private sector establishments.
These opportunities span various commercial, sports, entertainment, and industrial fields, aiming to enhance service levels, improve quality of life, and boost regional investment.
The municipality invited interested investors to review the opportunities and competition details through Furas at https://furas.momra.gov.sa/.
Iran’s President Masoud Pezeshkian discussed, in a phone call on Wednsday, with his French counterpart Emmanuel Macron, the latest security developments in the Middle East.
During the call, the two presidents discussed the repercussions of the assassination of Ismail Haniyeh, head of the political bureau of Hamas in Tehran, and the escalation in the Middle East, especially the ongoing Israeli aggression on the Gaza Strip, and southern Lebanon. (QNA)
The Prime Minister of Lebanon’s Caretaker Government, Najib Mikati met, on Wednesday, with his cabinet members, to discuss the readiness for any potential emergency or expansion of the Israeli aggression on his country.
In a statement of the office of the Prime Minister, Minister of Environment and coordinator of the national emergency committee in Lebanon, Nasser Yassin, said all ministries, official administrations and partner international organizations are implementing an emergency plan, in addition to addressing suppliers to provide larger quantities of food and other essential needs.
He outlined that the government discussed five fundamental points, shelter, ways to improve and equip shelters, health facilities, the emergency plan being crafted by the Ministry of Health, as well as food supplies.
Food importers confirmed that there are adequate quantities of food and fuel available, noting that supply levels are still maintaining their normal status, and supply lines are continuing to operate normall
y. They added that the Beirut-Rafic Hariri International Airport, maritime facilities, and infrastructure in Lebanon have been put on a full alert.
The southern regions of Lebanon have been experiencing persistent Israeli offensive amid concerns about expansion of the cycle of confrontations in the Middle East. (QNA)
Iraqi security authorities announced on Wednesday arresting four people accused of being responsible for the recent rocket attack on Al Asad Air Base, which hosts US soldiers and Global Coalition to Defeat ISIS advisors.
On August 5, Al Asad Air Base, west of the Anbar Province, came under attack by two rockets, launched from a vehicle within Haditha district, injuring five US soldiers and two contractors. (QNA)
Doha, August 07 (QNA) – Qatar Red Crescent Society (QRCS) announced Wednesday that it has conducted a comprehensive assessment of multi-sectoral needs in various areas of northern Syria, with the aim of forming a comprehensive and updated picture of the most important humanitarian and development needs at the regional level during the period (2024-2025).
In a statement, QRCS indicated that the 2024 program for these needs, which it has been doing for the past seven years, includes surveying and evaluating 146 local communities in the villages of northern Syria, including 88 villages in Idlib and its countryside and 58 villages in the Aleppo countryside.
QRCS pointed out that the areas with a population of more than 5,000 people were selected based on the census table issued by the United Nations Office for the Coordination of Humanitarian Affairs (OCHA) for 2023, which was issued at the beginning of 2024.
The multi-sectoral needs assessment is considered an essential part of QRCS’s ongoing efforts to provi
de humanitarian and development assistance to poor communities affected by humanitarian crises worldwide by adapting the assistance provided according to the real needs of different communities and the requirements of their living conditions. (QNA)
Head of the Nephrology Department at Al-Shifa Medical Complex in Gaza Dr. Ghazi Alyazji warned of the serious repercussions on the lives of kidney patients residing in the Gaza and North governorates, who were greatly affected by the ongoing Israeli occupation genocide on the Strip, during which the occupation murdered many of them.
In exclusive remarks to Qatar News Agency (QNA), Dr. Alyazji said that the war claimed the lives of various kidney patients for several reasons, the first of which was the forced cessation of kidney dialysis machines after the occupation forces destroyed the Al-Shifa Medical Complex, and the kidney dialysis department went out of service before it was partially restarted. He emphasized that the cessation of kidney dialysis operations during the periods of the ground invasion led to the accumulation of fluids in the patients’ bodies, and an increase in the percentage of potassium and urea in them, which further complicated their health condition, and led to the death of a number o
f them.
He indicated that the second reason is that kidney patients are affected by the famine that is sweeping the residents of northern Gaza as a result of the occupation forces preventing the entry of vegetables, meat, and fruits. He pointed out that kidney patients need a diet based on fruits and vegetables, and to stay away from canned foods that contain a high percentage of preservatives, which leads to an increase in the percentage of phosphorus and urea in them, and thus causes them health complications. He noted that the absence of healthy food and the increase in water pollution caused the deterioration of the health of a number of patients whose conditions were stable, and they now need a life-saving dialysis operation.
He pointed out that the Ministry of Health in Gaza is making efforts to restore and operate some of the departments that were destroyed by the occupation, as the nephrology department in the Al-Shifa Medical Complex was rehabilitated and 21 dialysis machines were re-operated out o
f the 70 that were operating before they were destroyed by the Israeli army. He indicated that to overcome the shortage of dialysis machines, medical supplies, laboratory equipment, and the severe shortage of fuel needed to operate the department, the medical teams reduced the number of weekly dialysis sessions that the patient needs, which affected the health condition of a number of patients.
The Head of the Nephrology Department at Al-Shifa Medical Complex in Gaza stressed that the occupation army destroyed the water treatment unit of the kidney dialysis department, which is designated for the operation of the devices, forcing the medical teams to use well water that reduces the efficiency of the devices. He appealed to international health organizations and institutions to intervene urgently to compensate for the needs of kidney patients in terms of devices, medicines, medical supplies, and laboratory tools to preserve their lives, as death threatens them at any moment.
The Ministry of Health in the Gaz
a Strip had warned of the danger to the lives of a thousand kidney dialysis patients due to the severe shortage of medicines and medical supplies, explaining that hospitals and health centers suffer from a severe shortage of medicines and medical supplies necessary to continue providing the necessary medical services to save the lives of patients and the injured, whose stock has become zero, or is about to run out.
In turn, the Euro-Mediterranean Human Rights Monitor in Gaza said that it records various daily deaths resulting from the arbitrary siege imposed by the Israeli entity on the Gaza Strip, and its continued prevention of the entry of medical supplies, especially kidney patients and the elderly who need medicines, treatment, and appropriate health care. (QNA)
The Israeli occupation forces (IOF) have arrested at least 26 Palestinians since yesterday evening until this morning in the West Bank, including siblings and former detainees.
In a joint statement on Wednesday, Palestinian Commission of Detainees and Ex-Detainees Affairs and Palestinian Prisoner’s Society (PPS) said that the number of arrests in the West Bank since Oct. 7 has reached around 10,000, including all segments of Palestinian society, in addition to the arrest of dozens of workers and thousands from Gaza, without knowing their exact numbers and identities yet, as the Israeli occupation continues to carry out the crime of enforced disappearance against them.
The statement pointed out that the ongoing and escalating arrest campaigns for ten months were accompanied by field executions, direct shooting before arrest, or threats of such, in addition to severe beatings, field investigations that affected hundreds, the use of police dogs, and the use of citizens as human shields and hostages, in additio
n to the widespread acts of vandalism that affected homes, and the seizure of belongings, cars, money, gold jewelry, and electronic devices, in addition to the demolition and bombing of homes belonging to detainees in the occupation prisons.
The occupation escalated its aggression on areas in the West Bank, coinciding with its genocide on the Gaza Strip, which resulted in dozens of martyrs and thousands of detainees. (QNA)
GlobeNewswire Distribution ID 1000985126